A statement released earlier today by Zacks Investment Research about Cooper Companies Inc (NYSE:COO) bumps the target price to $198.00
- Updated: October 5, 2016
Yesterday Cooper Companies Inc (NYSE:COO) traded 0.05% higher at $177.19. The company’s 50-day moving average is $183.89 and its 200-day moving average is $170.03. The last stock close price is up 4.08% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 240,316 shares of the stock were exchanged, down from an average trading volume of 524,782
Cooper Companies Inc (NYSE:COO) had its target price raised to $198.00 by Zacks Investment Research in a report released 10/05/2016. The new target price indicates a possible upside of 0.12% based on the company's last stock close price.
Previously on 9/5/2016, BMO Capital Markets reported about Cooper Companies Inc (NYSE:COO) raised the target price from $199.00 to $206.00. At the time, this indicated a possible upside of 0.11%.
See Chart Below
Cooper Companies Inc has a 52 week low of $119.28 and a 52 week high of $190.99 with a P/E ratio of 34.65 The company’s market cap is currently $0.
In addition to Zacks Investment Research reporting its target price, a total of 12 firms have reported on the stock. The consensus target price is $186.50 with 6 firms rating the stock a strong buy, 4 firms rating the stock a buy, 5 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.
About Cooper Companies Inc (NYSE:COO)
The Cooper Companies, Inc. (Cooper) is a medical device company. The Company operates through two business units: CooperVision, Inc. (CooperVision) and CooperSurgical, Inc. (CooperSurgical). CooperVision develops, manufactures and markets a range of soft contact lenses for the vision correction market. CooperVision offers Biofinity monthly spherical, toric and multifocal lenses under the Avaira brand. CooperVision markets single-use spherical, toric and multifocal lenses under clariti 1day brand and a single-use silicone hydrogel spherical lens under MyDay. CooperSurgical develops, manufactures and markets medical devices and procedure solutions to improve healthcare delivery to women. CooperSurgical participates in the market for women's healthcare with its product lines in approximately three categories based on the point of healthcare delivery: hospitals and surgical centers, obstetricians and gynecologists' medical offices, and fertility clinics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.